Abiopharma

🔍 DeWalch D Mark (Director)

Company: Black Stone Minerals, L.P. (BSM)

Report Date: 2026-04-02

Detailed Transactions and Holdings:

• Acquired 1,240 shares of Common units representing limited partner interests at $15.12 per share (Direct)
  Date: 2026-04-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 393,845.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common units representing limited partner interests (Direct)
  Date: 2026-04-02 | Code: H | nature_of_ownership: By DeWalch Diversified LP | shares_owned_after: 558,522.00
• Holds 0 shares of Common units representing limited partner interests (Direct)
  Date: 2026-04-02 | Code: H | nature_of_ownership: By Donald Mark DeWalch Trust | shares_owned_after: 40,809.00
• Holds 0 shares of Common units representing limited partner interests (Direct)
  Date: 2026-04-02 | Code: H | nature_of_ownership: By wife | shares_owned_after: 6,749.00

Footnotes:

• F1: Pursuant to a previous arrangement, the Reporting Person elected to receive common units in lieu of a cash retainer for service on the Board of Directors of the Partnership's General Partner.